NO164295B - ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS. - Google Patents
ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS. Download PDFInfo
- Publication number
- NO164295B NO164295B NO861486A NO861486A NO164295B NO 164295 B NO164295 B NO 164295B NO 861486 A NO861486 A NO 861486A NO 861486 A NO861486 A NO 861486A NO 164295 B NO164295 B NO 164295B
- Authority
- NO
- Norway
- Prior art keywords
- triazole
- formula
- alkyl
- difluorobenzyl
- compound
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 23
- 238000002360 preparation method Methods 0.000 title description 4
- KUFNEMCYFOJAGR-UHFFFAOYSA-N 4-benzyl-2h-triazole Chemical class C=1C=CC=CC=1CC1=CNN=N1 KUFNEMCYFOJAGR-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 37
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 239000007858 starting material Substances 0.000 claims description 14
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 7
- 150000002431 hydrogen Chemical class 0.000 claims description 7
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 claims description 5
- REQQDJGYRQVUEY-UHFFFAOYSA-N 1-[(2,5-difluorophenyl)methyl]triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=C(C(=O)N)N=NN1CC1=CC(F)=CC=C1F REQQDJGYRQVUEY-UHFFFAOYSA-N 0.000 claims description 3
- DJBPPAUNFOJQJT-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=C(C(=O)N)N=NN1CC1=C(F)C=CC=C1F DJBPPAUNFOJQJT-UHFFFAOYSA-N 0.000 claims description 3
- XQMDOHQLLSYYGH-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=C(C(=O)N)N=NN1CC1=CC=CC=C1F XQMDOHQLLSYYGH-UHFFFAOYSA-N 0.000 claims description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 3
- 229910052731 fluorine Inorganic materials 0.000 claims description 3
- 239000011737 fluorine Substances 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- HDIBQANHVXCQBC-UHFFFAOYSA-N 2h-triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=NNN=C1C(N)=O HDIBQANHVXCQBC-UHFFFAOYSA-N 0.000 claims description 2
- 150000003857 carboxamides Chemical class 0.000 claims description 2
- 125000004997 halocarbonyl group Chemical group 0.000 claims description 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 46
- -1 acetylcarbamoyl Chemical group 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical group C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 238000009835 boiling Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- JSZUBPHMRHROHZ-UHFFFAOYSA-N 2-(azidomethyl)-1,3-difluorobenzene Chemical compound FC1=CC=CC(F)=C1CN=[N+]=[N-] JSZUBPHMRHROHZ-UHFFFAOYSA-N 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 238000000354 decomposition reaction Methods 0.000 description 5
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 229960000583 acetic acid Drugs 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- LUEHNHVFDCZTGL-UHFFFAOYSA-N but-2-ynoic acid Chemical compound CC#CC(O)=O LUEHNHVFDCZTGL-UHFFFAOYSA-N 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- BFUIERXAICVUAH-UHFFFAOYSA-N 2-(2-azidopropan-2-yl)-1,3-difluorobenzene Chemical compound [N-]=[N+]=NC(C)(C)C1=C(F)C=CC=C1F BFUIERXAICVUAH-UHFFFAOYSA-N 0.000 description 3
- FFCSQJRDCQEBGZ-UHFFFAOYSA-N 2-(azidomethyl)-1-chloro-3-fluorobenzene Chemical compound FC1=CC=CC(Cl)=C1CN=[N+]=[N-] FFCSQJRDCQEBGZ-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000007098 aminolysis reaction Methods 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- VHILMKFSCRWWIJ-UHFFFAOYSA-N dimethyl acetylenedicarboxylate Chemical compound COC(=O)C#CC(=O)OC VHILMKFSCRWWIJ-UHFFFAOYSA-N 0.000 description 3
- 150000002367 halogens Chemical group 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- SIYWDKQSSDBLOA-UHFFFAOYSA-N 1-(2,6-difluorophenyl)ethanol Chemical compound CC(O)C1=C(F)C=CC=C1F SIYWDKQSSDBLOA-UHFFFAOYSA-N 0.000 description 2
- WJSUIHLKOGPGRY-UHFFFAOYSA-N 1-(azidomethyl)-2-fluorobenzene Chemical compound FC1=CC=CC=C1CN=[N+]=[N-] WJSUIHLKOGPGRY-UHFFFAOYSA-N 0.000 description 2
- RYIYZDSRGWJEGQ-UHFFFAOYSA-N 1-[(2-chloro-6-fluorophenyl)methyl]triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=C(C(=O)N)N=NN1CC1=C(F)C=CC=C1Cl RYIYZDSRGWJEGQ-UHFFFAOYSA-N 0.000 description 2
- SWVCWRVIISPNQX-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]triazole-4-carboxamide Chemical compound N1=NC(C(=O)N)=CN1CC1=CC=CC=C1F SWVCWRVIISPNQX-UHFFFAOYSA-N 0.000 description 2
- QOQJFBGZXPUNOZ-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]triazole-4-carboxylic acid Chemical class N1=NC(C(=O)O)=CN1CC1=CC=CC=C1F QOQJFBGZXPUNOZ-UHFFFAOYSA-N 0.000 description 2
- MJGOLNNLNQQIHR-UHFFFAOYSA-N 1-chloro-2-(chloromethyl)-3-fluorobenzene Chemical compound FC1=CC=CC(Cl)=C1CCl MJGOLNNLNQQIHR-UHFFFAOYSA-N 0.000 description 2
- CXBDYQVECUFKRK-UHFFFAOYSA-N 1-methoxybutane Chemical group CCCCOC CXBDYQVECUFKRK-UHFFFAOYSA-N 0.000 description 2
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 2
- CNHYBCSUCCQPIN-UHFFFAOYSA-N 2-(1-azidoethyl)-1,3-difluorobenzene Chemical compound [N-]=[N+]=NC(C)C1=C(F)C=CC=C1F CNHYBCSUCCQPIN-UHFFFAOYSA-N 0.000 description 2
- UJWAUSOIPNQBDB-UHFFFAOYSA-N 2-(2,6-difluorophenyl)propan-2-ol Chemical compound CC(C)(O)C1=C(F)C=CC=C1F UJWAUSOIPNQBDB-UHFFFAOYSA-N 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- JBTGHKUTYAMZEZ-UHFFFAOYSA-N acetylene dicarboxylic acid diamide Natural products NC(=O)C#CC(N)=O JBTGHKUTYAMZEZ-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000005915 ammonolysis reaction Methods 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- POGQSBRIGCQNEG-UHFFFAOYSA-N rufinamide Chemical compound N1=NC(C(=O)N)=CN1CC1=C(F)C=CC=C1F POGQSBRIGCQNEG-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- WKFYEWXSRFQOKX-UHFFFAOYSA-N 1,4-dioxane;toluene Chemical compound C1COCCO1.CC1=CC=CC=C1 WKFYEWXSRFQOKX-UHFFFAOYSA-N 0.000 description 1
- VGIIILXIQLXVLC-UHFFFAOYSA-N 1-(2,6-difluorophenyl)ethanone Chemical compound CC(=O)C1=C(F)C=CC=C1F VGIIILXIQLXVLC-UHFFFAOYSA-N 0.000 description 1
- FVFRGKBIKRFGNG-UHFFFAOYSA-N 1-(azidomethyl)-2,4-difluorobenzene Chemical compound FC1=CC=C(CN=[N+]=[N-])C(F)=C1 FVFRGKBIKRFGNG-UHFFFAOYSA-N 0.000 description 1
- ZUZAISZPNMFDNK-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=C(C(=O)N)N=NN1CC1=CC=CC(F)=C1F ZUZAISZPNMFDNK-UHFFFAOYSA-N 0.000 description 1
- OVOGQGWKYZSKHB-UHFFFAOYSA-N 1-[(2,3-difluorophenyl)methyl]triazole-4-carboxamide Chemical compound N1=NC(C(=O)N)=CN1CC1=CC=CC(F)=C1F OVOGQGWKYZSKHB-UHFFFAOYSA-N 0.000 description 1
- VTODDLDPFCXAJU-UHFFFAOYSA-N 1-[(2,4-difluorophenyl)methyl]triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=C(C(=O)N)N=NN1CC1=CC=C(F)C=C1F VTODDLDPFCXAJU-UHFFFAOYSA-N 0.000 description 1
- WJTQKIBPEOJOIK-UHFFFAOYSA-N 1-[(2,4-difluorophenyl)methyl]triazole-4-carboxamide Chemical compound N1=NC(C(=O)N)=CN1CC1=CC=C(F)C=C1F WJTQKIBPEOJOIK-UHFFFAOYSA-N 0.000 description 1
- FLTHNEGZLIPLGL-UHFFFAOYSA-N 1-[(2,5-difluorophenyl)methyl]triazole-4-carboxamide Chemical compound N1=NC(C(=O)N)=CN1CC1=CC(F)=CC=C1F FLTHNEGZLIPLGL-UHFFFAOYSA-N 0.000 description 1
- UUGJJIXRRVZNNX-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]-5-methyltriazole-4-carboxamide Chemical compound CC1=C(C(N)=O)N=NN1CC1=C(F)C=CC=C1F UUGJJIXRRVZNNX-UHFFFAOYSA-N 0.000 description 1
- BSKYMXVRPQKKNE-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]-5-methyltriazole-4-carboxylic acid Chemical compound CC1=C(C(O)=O)N=NN1CC1=C(F)C=CC=C1F BSKYMXVRPQKKNE-UHFFFAOYSA-N 0.000 description 1
- OPJHWTKDQYKYHL-UHFFFAOYSA-N 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxylic acid Chemical compound N1=NC(C(=O)O)=CN1CC1=C(F)C=CC=C1F OPJHWTKDQYKYHL-UHFFFAOYSA-N 0.000 description 1
- YGJSCFVQYUIZMC-UHFFFAOYSA-N 1-[(2-chloro-6-fluorophenyl)methyl]triazole-4-carboxamide Chemical compound N1=NC(C(=O)N)=CN1CC1=C(F)C=CC=C1Cl YGJSCFVQYUIZMC-UHFFFAOYSA-N 0.000 description 1
- VYWRVJMXJSWKDJ-UHFFFAOYSA-N 1-[(2-chloro-6-fluorophenyl)methyl]triazole-4-carboxylic acid Chemical compound N1=NC(C(=O)O)=CN1CC1=C(F)C=CC=C1Cl VYWRVJMXJSWKDJ-UHFFFAOYSA-N 0.000 description 1
- QFDXECSWYQYNJR-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]triazole-4,5-dicarboxamide Chemical compound NC(=O)C1=C(C(=O)N)N=NN1CC1=CC=CC=C1Cl QFDXECSWYQYNJR-UHFFFAOYSA-N 0.000 description 1
- IGQSJOPLGHVOSH-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]triazole-4-carboxamide Chemical compound N1=NC(C(=O)N)=CN1CC1=CC=CC=C1Cl IGQSJOPLGHVOSH-UHFFFAOYSA-N 0.000 description 1
- CVENKRUGWFPASK-UHFFFAOYSA-N 1-[1-(2,6-difluorophenyl)ethyl]triazole-4-carboxylic acid Chemical compound C1=C(C(O)=O)N=NN1C(C)C1=C(F)C=CC=C1F CVENKRUGWFPASK-UHFFFAOYSA-N 0.000 description 1
- FNPVYRJTBXHIPB-UHFFFAOYSA-N 1-chloro-3-fluoro-2-methylbenzene Chemical compound CC1=C(F)C=CC=C1Cl FNPVYRJTBXHIPB-UHFFFAOYSA-N 0.000 description 1
- VLRKJKIPXIYUFM-UHFFFAOYSA-N 2-(azidomethyl)-1,4-difluorobenzene Chemical compound FC1=CC=C(F)C(CN=[N+]=[N-])=C1 VLRKJKIPXIYUFM-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- YTIVTFGABIZHHX-UHFFFAOYSA-N butynedioic acid Chemical compound OC(=O)C#CC(O)=O YTIVTFGABIZHHX-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- JRZBPELLUMBLQU-UHFFFAOYSA-N carbonazidic acid Chemical compound OC(=O)N=[N+]=[N-] JRZBPELLUMBLQU-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- MLMYKFGHSDQFOG-UHFFFAOYSA-N dimethyl 1-[(2,4-difluorophenyl)methyl]triazole-4,5-dicarboxylate Chemical compound COC(=O)C1=C(C(=O)OC)N=NN1CC1=CC=C(F)C=C1F MLMYKFGHSDQFOG-UHFFFAOYSA-N 0.000 description 1
- VGFGLTAGKOYIOK-UHFFFAOYSA-N dimethyl 1-[(2,5-difluorophenyl)methyl]triazole-4,5-dicarboxylate Chemical compound COC(=O)C1=C(C(=O)OC)N=NN1CC1=CC(F)=CC=C1F VGFGLTAGKOYIOK-UHFFFAOYSA-N 0.000 description 1
- ONTXMYJNWYGNQE-UHFFFAOYSA-N dimethyl 1-[(2,6-difluorophenyl)methyl]triazole-4,5-dicarboxylate Chemical compound COC(=O)C1=C(C(=O)OC)N=NN1CC1=C(F)C=CC=C1F ONTXMYJNWYGNQE-UHFFFAOYSA-N 0.000 description 1
- YNQOPEURYRMULB-UHFFFAOYSA-N dimethyl 1-[(2-fluorophenyl)methyl]triazole-4,5-dicarboxylate Chemical compound COC(=O)C1=C(C(=O)OC)N=NN1CC1=CC=CC=C1F YNQOPEURYRMULB-UHFFFAOYSA-N 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- LGCFDUVFDLUCDE-UHFFFAOYSA-N ethyl 1-[1-(2,6-difluorophenyl)ethyl]triazole-4-carboxylate Chemical compound N1=NC(C(=O)OCC)=CN1C(C)C1=C(F)C=CC=C1F LGCFDUVFDLUCDE-UHFFFAOYSA-N 0.000 description 1
- FBQKPNPHWYPJFU-UHFFFAOYSA-N ethyl 2,6-difluorobenzoate Chemical compound CCOC(=O)C1=C(F)C=CC=C1F FBQKPNPHWYPJFU-UHFFFAOYSA-N 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 150000004820 halides Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- NRUBUZBAZRTHHX-UHFFFAOYSA-N lithium;propan-2-ylazanide Chemical compound [Li+].CC(C)[NH-] NRUBUZBAZRTHHX-UHFFFAOYSA-N 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- LRTQFGQTBAXESK-UHFFFAOYSA-N pent-3-ynamide Chemical compound CC#CCC(N)=O LRTQFGQTBAXESK-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
Description
Oppfinnelsen vedrører en analogifremgangsmåte til fremstil- The invention relates to an analogous method for manufacturing
ling av terapeutisk anvendbare, fluorerte l-(a-fenylalkyl)-1H-1,2,3-triazolforbindelser med formel ling of therapeutically useful, fluorinated 1-(α-phenylalkyl)-1H-1,2,3-triazole compounds of formula
hvori Ph betyr en i o-stilling med fluor og eventuelt i tillegg et ytterligere halogenatom substituert fenylrest, alk betyr Cj,-C3-alkyliden, R^ betyr hydrogen, C1-C4-alkyl, eller en usubstituert eller med C^-C4-alkanoyl eller C^-C4~alkyl substituert karbamylgruppe, og R2 betyr en usubstituert eller med Ci-C4-alkanoyl eller C^-C4-alkyl substituert karbamyl- in which Ph means an i o-position with fluorine and optionally in addition a further halogen atom substituted phenyl residue, alk means Cj,-C3-alkylidene, R^ means hydrogen, C1-C4-alkyl, or an unsubstituted or with C^-C4- alkanoyl or C 1 -C 4 -alkyl substituted carbamyl group, and R 2 means an unsubstituted or with C 1 -C 4 -alkanoyl or C 1 -C 4 -alkyl substituted carbamyl-
gruppe . group.
Som ekstra halogensubstituenter av Ph, kommer halogenatomer As additional halogen substituents of Ph, halogen atoms come
med atomnummer til og med 35, som fluor eller klor i betraktning. with atomic numbers up to and including 35, such as fluorine or chlorine in consideration.
C^-Cs-alkyliden er eksempelvis metylen, videre etyliden, 1,1-propyliden eller 2,2-propyliden (isopropyliden). The C 1 -C 5 alkylidene is, for example, methylene, further ethylidene, 1,1-propylidene or 2,2-propylidene (isopropylidene).
Ci-C4-alkyl er eksempelvis metyl eller i annen rekke etyl, Ci-C4-alkyl is, for example, methyl or, in other words, ethyl,
propyl, isopropyl, butyl, isobutyl, sekundær butyl eller tertiær butyl. propyl, isopropyl, butyl, isobutyl, secondary butyl or tertiary butyl.
Med C1-C4-alkanoyl eller C^-C4-alkyl substituert karbamyl er With C1-C4-alkanoyl or C1-C4-alkyl substituted carbamyl is
spesielt med C^-C4-alkanoyl mono- eller med C1-C4~alkyl disubstituert og betyr eksempelvis N-Ci-C4-alkanoylkarbamyl, especially with C 1 -C 4 -alkanoyl mono- or with C 1 -C 4 -alkyl disubstituted and means for example N -C 1 -C 4 -alkanoylcarbamyl,
i første rekke N-C2-C4-alkanoylkarbamyl, som acetylkarbamoyl eller N,N-di-C^-C4-alkylkarbamyl, som N,N-dimetylkarbamyl eller N,N-dietylkarbamyl. primarily N-C2-C4-alkanoylcarbamyl, such as acetylcarbamoyl or N,N-di-C1-C4-alkylcarbamyl, such as N,N-dimethylcarbamyl or N,N-diethylcarbamyl.
De nye forbindelser med formel I har verdifulle farmakolo-giske egenskaper, spesielt en utpreget antikonvulsiv virkning, som lar seg vise eksempelvis på mus ved hjelp av en tydelig metrazol-antagonisme i - doseområder fra 30 til 300 mg/kg p.o., såvel på mus og rotte ved hjelp av en utpreget beskyttelsesvirkning mot elektrosjokk-utløste konvulsjoner i doseområder på ca. 1 til ca. 50, i de fleste tilfeller fra ca. 1 til ca. 25 mg/kg p.o. Sajnmenligningsforsøk utført med følgende forbindelser fremstilt ;ifølge oppfinnelsen: l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid, I; l-(o-fluorbenzyl)-lH-l,2,3-triazol-4-karboksamid, II; l-(2,6-di fluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid , III; l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4,5-dikarboksamid, IV; l-(o-fluorbenzyl )-lH-l,2,3-triazol-4,5-dikarboksamid, V; l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4-karboksamid, VI; l-(2,5-di fluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid , VII; med de strukturelt nærmestliggende kjente forbindelsene l-(o-klorbenzyl)-lH-l,2,3-triazol-4-karboksamid, IX og l-(o-klorbenzyl )-lH-l,2,3-triazol-4,5-dikarboksamid, X ifølge EP-A1-114 347, samt l-(o-klorbenzyl)-5-amino-lH-l,2, 3- tr i azol-4-karboksyl syr e-piperidid, XI ifølge GB-PS-1511195 ga verdiene angitt i den etterfølgende tabellen for den effektive dosen ED50 (ved 1 times forapplikasjon): The new compounds of formula I have valuable pharmacological properties, in particular a pronounced anticonvulsant effect, which can be shown, for example, in mice by means of a clear metrazole antagonism in - dose ranges from 30 to 300 mg/kg p.o., both in mice and rat by means of a pronounced protective effect against electroshock-triggered convulsions in dose ranges of approx. 1 to approx. 50, in most cases from approx. 1 to approx. 25 mg/kg p.o. Comparison experiments carried out with the following compounds prepared according to the invention: 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide, I; 1-(o-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide, II; 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, III; 1-(6-chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, IV; 1-(o-Fluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, V; 1-(6-Chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4-carboxamide, VI; 1-(2,5-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, VII; with the structurally closest known compounds 1-(o-chlorobenzyl)-1H-1,2,3-triazole-4-carboxamide, IX and 1-(o-chlorobenzyl)-1H-1,2,3-triazole-4, 5-dicarboxamide, X according to EP-A1-114 347, as well as 1-(o-chlorobenzyl)-5-amino-1H-1,2,3-tr iazole-4-carboxylic acid e-piperidide, XI according to GB- PS-1511195 gave the values indicated in the following table for the effective dose ED50 (at 1 hour pre-application):
Forbindelsene (I) til (VIII) fremstilt ifølge oppfinnelsen adskiller seg følgelig fra kjente, strukturanaloge forbindelser (IX) til (XI) ifølge teknikkens stand ved en vesentlig sterkere virkning og er følgelig utmerket egnet til behandling av konvulsjoner av forskjellig genese, eksempelvis til behandling av epilepsi, og kan anvendes som antikonvulsive, eksempelvis antlepileptisk virksomme stoffer i legemidler. The compounds (I) to (VIII) produced according to the invention consequently differ from known, structurally analogous compounds (IX) to (XI) according to the state of the art by having a significantly stronger effect and are consequently excellently suitable for the treatment of convulsions of different genesis, for example for the treatment of epilepsy, and can be used as anticonvulsants, for example antiepileptically active substances in pharmaceuticals.
Oppfinnelsen vedrører i første rekke fremstillingen av forbindelser med formel I, hvori Ph betyr o-fluorfenyl eller 2,6-difluorfenyl, alk står for metylen, R^ betyr hydrogen eller usubstituert karbamyl og R2 er usubstituert karbamyl. The invention primarily relates to the preparation of compounds of formula I, in which Ph means o-fluorophenyl or 2,6-difluorophenyl, alk stands for methylene, R 1 means hydrogen or unsubstituted carbamyl and R 2 is unsubstituted carbamyl.
Oppfinnelsen vedrører fortrinnsvis fremstilling av forbindelser med formel I, hvori Ph betyr 2 ,6-difluorfenyl, alk betyr metylen, R^ betyr hydrogen, C^-^-alkyl , som metyl eller en rest Rg>°g R2 DetYr karbamyl, N-C2~C5-alkanoylkarbamyl, som acetylkarbamyl eller N,N-di-C^-C4-alkylkarbamyl, som dimetylkarbamyl. The invention preferably relates to the preparation of compounds of formula I, in which Ph means 2,6-difluorophenyl, alk means methylene, R^ means hydrogen, C^-^-alkyl, such as methyl or a residue Rg>°g R2 DetYr carbamyl, N- C2~C5-alkanoylcarbamyl, such as acetylcarbamyl or N,N-di-C^-C4-alkylcarbamyl, such as dimethylcarbamyl.
Oppfinnelsen vedrører fremfor alt fremstillingen av forbindelser med formel J, iivorl Ph betyr o-fluorfenyl, 2,5-difluorfenyl, 2,6-difluorfenyl eller 2-klor-6-fluor-fenyl, alk står for metylen og 8^ og R2 betyr begge karbamyl, videre forbindelser av formel I hvori Ph betyr 2,6-difluorfenyl, alk betyr metylen, Ri betyr hydrogen eller karbamyl og R2 betyr karbamyl. The invention relates above all to the preparation of compounds of formula J, where Ph means o-fluorophenyl, 2,5-difluorophenyl, 2,6-difluorophenyl or 2-chloro-6-fluoro-phenyl, alk stands for methylene and 8^ and R2 means both carbamyl, further compounds of formula I in which Ph means 2,6-difluorophenyl, alk means methylene, R 1 means hydrogen or carbamyl and R 2 means carbamyl.
Fremgangsmåten til fremstilling av forbindelsen med formel I beror på i og for seg kjente metoder og er kjennetegnet ved at man The process for producing the compound of formula I is based on methods known per se and is characterized by the fact that
a) på kjent måte amiderer en forbindelse av formelen a) amidates a compound of the formula in a known manner
hvori R'i betyr hydrogen, C^-C^alkyl eller en gruppe av wherein R'i means hydrogen, C 1 -C 4 alkyl or a group of
formelen -COOR3 og R'2 betyr en gruppe -C00R3, hvorved R3 er C^-C^-alkyl , eller R'i er hydrogen eller C^-C^alkyl og R'2 er halogenkarbonyl, eller the formula -COOR3 and R'2 means a group -C00R3, whereby R3 is C^-C^-alkyl, or R'i is hydrogen or C^-C^alkyl and R'2 is halocarbonyl, or
b) omsetter en forbindelse av formelen b) reacts a compound of the formula
med en forbindelse av formelen with a compound of the formula
som eventuelt kan foreligge-i tautomer form, which may possibly exist-in tautomeric form,
hvori Ri betyr Ci-C4-alkyl, Yj betyr hydroksy og Y2 .betyr hydrogen eller Rj betyr hydrogen, karbamyl eller Ci-C4~alkyl in which Ri means C1-C4-alkyl, Yj means hydroxy and Y2 means hydrogen or Rj means hydrogen, carbamyl or C1-C4-alkyl
og Yi og Y2 danner sammen en ekstra binding, hvorved R2 i et hvert tilfelle er karbamyl, eller and Y1 and Y2 together form an additional bond, whereby R2 in each case is carbamyl, or
c) omsetter en forbindelse av formelen c) reacts a compound of the formula
hvori Z står for reaktivt forestret hydroksy, med 1,2,3-triazol-4,5-dikarboksamid og, om ønsket, i den ifølge a), b) eller c) oppnådde forbindelsen med formel I acyleres den usubstituerte karbamyl gruppen R2 og eventuelt R! .' Overføringen av de nevnte gruppene R'2 og eventuelt R'^ til eventuelt C^-C^-alkylert karbamyl ifølge fremgangsmåtevariant a) foregår på vanlig måte ved ; ammonolyse, henholdsvis aminolyse (omsetning med ammoniakk eller et Ci-C4-alkylamin). in which Z stands for reactively esterified hydroxy, with 1,2,3-triazole-4,5-dicarboxamide and, if desired, in the compound of formula I obtained according to a), b) or c) the unsubstituted carbamyl group R2 is acylated and possibly R! .' The transfer of the aforementioned groups R'2 and optionally R'^ to optionally C^-C^-alkylated carbamyl according to method variant a) takes place in the usual way by; ammonolysis, respectively aminolysis (reaction with ammonia or a Ci-C4 alkylamine).
Ved ammonolysen, henholdsvis aminolysen arbeider man, om nødvendig, i nærvær av et kondensasjonsmiddel, fortrinnsvis i et inert oppløsningsmiddel. Kondensasjonsmidler er basiske kondensasjonsmidlér, fremfor alt ammoniakk, henholdsvis for aminolysen anvendte aminer i overskudd, med utgangspunkt i halogenidformen foreliggende karboksy, videre alkalimetall-hydroksyder eller -karbonater eller tertiære : organiske nitrogenbaser, som trilaverealkylaminer eller tertiære heteroaromatiske nitrogenbaser, som trietylamin eller pyridin. In the case of the ammonolysis, respectively the aminolysis, one works, if necessary, in the presence of a condensing agent, preferably in an inert solvent. Condensing agents are basic condensation agents, above all ammonia, respectively amines used for the aminolysis in excess, starting from the carboxy present in the halide form, further alkali metal hydroxides or carbonates or tertiary: organic nitrogen bases, such as trilower alkylamines or tertiary heteroaromatic nitrogen bases, such as triethylamine or pyridine.
En spesielt foretrukket utførelsesform av denne fremgangs-måtevarianten er kjennetegnet ved at man omsetter en forbindelse av formel I', hvori R'2 betyr en gruppe -COOR3 og R'l betyr hydrogen, Ci-C4~alkyl eller eventuelt en gruppe A particularly preferred embodiment of this method variant is characterized by reacting a compound of formula I', in which R'2 means a group -COOR3 and R'1 means hydrogen, C1-C4~alkyl or optionally a group
-COOR3, med et overskudd av ammoniakk eller et di-Ci~C4-alkylamin, og, om ønsket, i en ved fremgangsmåten oppnådd forbindelse, hvtiri R2 og eventuelt R^ betyr usubstituert karbamyl, Ci-C4-alkanoylierer R2 og eventuelt R^. Utgangsstoffene (I') kan, så fremt de ikke er kjente, fremstilles på vanlig måte, eksempelvis ved at man omsetter et azid av formelen med en forbindelse av formelen eksempelvis på analog måte som beskrevet under fremgangsmåtevariant b). Om nødvendig kan primært oppnådde estere henholdsvis nitriler med formelen I', (R'2 = forestret karboksy eller cyano) hydrolyseres til tilsvarende syre under basiske betingelser, f.eks. ved hjelp av vandig-alkoholisk natronlut, eller primært eller ved hydrolyse av tilsvarende estere eller nitriler oppnådde syrer med formelen (I, R'2 = Som utgangsstoffer med formel III for fremgangsmåtevariant b) kommer eksempelvis i betraktning forbindelser med formel Rj-CEC-R2 (Illa) og R1-C(=0)-CH2-R (IHb) (forbindelsen Illb er den tautomere formen av forbindelsen -COOR3, with an excess of ammonia or a di-Ci-C4-alkylamine, and, if desired, in a compound obtained by the process, where R2 and optionally R^ means unsubstituted carbamyl, Ci-C4-alkanoylates R2 and optionally R^ . The starting substances (I') can, as long as they are not known, be prepared in the usual way, for example by reacting an azide of the formula with a compound of the formula for example in an analogous way as described under method variant b). If necessary, primarily obtained esters or nitriles with the formula I', (R'2 = esterified carboxy or cyano) can be hydrolyzed to the corresponding acid under basic conditions, e.g. with the aid of aqueous-alcoholic caustic soda, or primarily or by hydrolysis of corresponding esters or nitriles obtained acids with the formula (I, R'2 = As starting materials with formula III for method variant b) for example compounds with the formula Rj-CEC-R2 are taken into consideration (Illa) and R1-C(=0)-CH2-R (IHb) (the compound Illb is the tautomeric form of the compound
(III; Yi = OH, (III; Yi = OH,
Y2 = H) ). Y2 = H) ).
Omsetningen av forbindelsene med II og III foregår på vanlig måte, fortrinnsvis i et inert oppløsningsmiddel, hvis nødvendig i nærvær av et kondensasjonsmiddel, og/eller ved forhøyet temperatur. Inerte oppløsningsmidler er eksempelvis aromatiske eller alifatiske hydrokarboner, som benzen eller toluen, eller eter som tertiærbutoksymetan, tetrahydrofuran og dioksan. The reaction of the compounds with II and III takes place in the usual way, preferably in an inert solvent, if necessary in the presence of a condensing agent, and/or at an elevated temperature. Inert solvents are, for example, aromatic or aliphatic hydrocarbons, such as benzene or toluene, or ethers such as tertiary butoxymethane, tetrahydrofuran and dioxane.
Foretrukkede utførelsesformer av denne fremgangsmåten er eksempelvis omsetningen av et azid med formel II med en forbindelse med formel Illa i benzen eller dioksan ved 60-120"C, fortrinnsvis koketemperatur. Preferred embodiments of this method are, for example, the reaction of an azide of formula II with a compound of formula Illa in benzene or dioxane at 60-120°C, preferably boiling temperature.
Utgangsstoffene med formel III og delvis med formel II er kjent. Nye utgangsstoffer med formel II kan fåes som analoge dannelsesmåter av de kjente, eksempelvis idet man omsetter en forbindelse med formel Ph-alk-Z IV, hvori Z betyr et reaksjonsdyktig, forestret hydroksy som halogen, f.eks. klor, brom eller jod, eller sulfonyloksy, som laverealkansulfonyloksy, eventuelt substituert benzensulfonyloksy, som metan-, etanbenzen-, p-toluen- eller p-brombenzensulfonyloksy eller fluorsulfonyloksy, med et alkalimetallåzid, f.eks. med natriumazid, eksempelvis dimetylsulfoksyd eller dimetylformamid, eller idet man bringer til reaksjon en alkohol med formel IV (Z = hydroksy) i nærvær av trifenylfosfin, og en azidodikarboksylsyreester, f.eks. azidokarboksylsyredietyles-ter med nitrogenhydrogensyre, eksempelvis i toluen. The starting substances with formula III and partly with formula II are known. New starting substances with formula II can be obtained as analogous formation methods of the known ones, for example by reacting a compound of formula Ph-alk-Z IV, in which Z means a reactive, esterified hydroxy such as halogen, e.g. chlorine, bromine or iodine, or sulfonyloxy, such as lower alkanesulfonyloxy, optionally substituted benzenesulfonyloxy, such as methane-, ethanebenzene, p-toluene- or p-bromobenzenesulfonyloxy or fluorosulfonyloxy, with an alkali metal azide, e.g. with sodium azide, for example dimethylsulfoxide or dimethylformamide, or by reacting an alcohol of formula IV (Z = hydroxy) in the presence of triphenylphosphine, and an azidodicarboxylic acid ester, e.g. azidocarboxylic acid diethyl ester with nitric acid, for example in toluene.
I utgangsstoffer IV ifølge fremgangsmåtevariant c) betyr reaksjonsdyktig forestret hydroksy eksempelvis halogen, f.eks. klor, brom eller jod, eller sulfonyloksy, som laverealkansulfonyloksy eller eventuelt substituert benzensulfonyloksy, som metan-, etan-, benzen-, p-toluen- eller p-brombenzensulfonyloksy eller fluorsulfonyloksy. In starting materials IV according to process variant c), reactive esterified hydroxy means, for example, halogen, e.g. chlorine, bromine or iodine, or sulfonyloxy, such as lower alkanesulfonyloxy or optionally substituted benzenesulfonyloxy, such as methane, ethane, benzene, p-toluene or p-bromobenzenesulfonyloxy or fluorosulfonyloxy.
Omsetningen foregår på vanlig måte, eksempelvis i nærvær av et basisk kondensasjonsmiddel, eller fordelaktig idet man anvender 1H-1,2,3-triazolkomponenter som salt, hvis nødvendig under oppvarming, fortrinnsvis i et oppløsnings- eller fortynningsmiddel. Basiske kondensasjonsmidler er eksempelvis med 1H-1,2,3-triazoikomponenten saltdannende basiske kondensasjonsmidler, som alkalimetallalkoholater, f.eks. natriummetanolat eller natriumetanolat, alkalimetall-, eller jordalkalimetallamider f.eks. natriumamid, eller litiumiso-propylamid. Overføringen av 1H-1,2,3-triazolkomponentene i et av deres salter gjennomføres fortrinnsvis på forhånd, f.eks. ved omsetning med en av de nevnte baser. Oppløsnings-midler er for gjennomføringen av omsetningen i nærvær av et alkoholat fortrinnsvis i tilsvarende alkoholer og ved gjennomføringen i nærvær av amider eksempelvis aprotiske, organiske oppløsningsmidler, som fosforsyrelaverealkylamider, f.eks. heksametylfosforsyretriamid, alkansyreamid, f.eks. dimetylformamid, eller dilaverealkylsulfoksyder, f.eks. dimetylsulfoksyd. Ifølge fremgangsmåten som biprodukt dannede isomere adskilles eventuelt fra de ønskede forbindelser med formel I. The reaction takes place in the usual way, for example in the presence of a basic condensing agent, or advantageously using 1H-1,2,3-triazole components as salt, if necessary under heating, preferably in a solvent or diluent. Basic condensing agents are, for example, salt-forming basic condensing agents with the 1H-1,2,3-triazo component, such as alkali metal alcoholates, e.g. sodium methanolate or sodium ethanolate, alkali metal or alkaline earth metal amides, e.g. sodium amide, or lithium isopropylamide. The transfer of the 1H-1,2,3-triazole components into one of their salts is preferably carried out in advance, e.g. by turnover with one of the aforementioned bases. Solvents for carrying out the reaction in the presence of an alcoholate are preferably corresponding alcohols and when carried out in the presence of amides, for example, aprotic, organic solvents, such as phosphoric acid lower alkyl amides, e.g. hexamethylphosphoric acid triamide, alkanoic acid amide, e.g. dimethylformamide, or dilave alkyl sulphoxides, e.g. dimethyl sulfoxide. According to the method, isomers formed as by-products are optionally separated from the desired compounds of formula I.
Utgangsstof f ene IV kan, hvis de ikke allerede er kjent, fremstilles på vanlig måte. Således får man forbindelser med formel IV f.eks., idet man reaksjonsdyktig forestrer en tilsvarende alkohol (IV, Z = hydroksy), f.eks. ved hjelp av tionylklorid, fosfortribromid, eller et sulfonylklorid. Starting substances f ene IV can, if they are not already known, be prepared in the usual way. Thus compounds of formula IV are obtained, for example, by esterifying a corresponding alcohol (IV, Z = hydroxy) in a reactive manner, e.g. using thionyl chloride, phosphorus tribromide, or a sulfonyl chloride.
Som omvandlingsreaksjoner for forbindelser oppnådd ved fremgangsmåten til andre forbindelser med formel (I) skal spesielt nevnes substitusjonsreaksjoner på N-usubstituerte eller N-monolaverealkylsubstituerte karbamylgrupper B£ og/eller R^ samt oppdelingen av isomerblandinger oppnådd ved fremgangsmåten. As conversion reactions for compounds obtained by the method to other compounds of formula (I) special mention must be made of substitution reactions on N-unsubstituted or N-monolower alkyl substituted carbamyl groups B£ and/or R^ as well as the division of isomer mixtures obtained by the method.
Følgelig kan man i forbindelser med formel (I) ved behandling med et Ci-C4-alkanoyleringsmiddel overføre N-usubstituert karbamyl til N-Ci-C4-alkanoylkarbamyl. Consequently, in compounds of formula (I) by treatment with a C1-C4-alkanoylating agent, N-unsubstituted carbamyl can be converted to N-C1-C4-alkanoylcarbamyl.
Ci-C4-alkanoyleringsmidler er eksempelvis Ci-C4-alkankarbok-sylsyreanhydrider som acetanhydrid eller det blandede anhydrid av maur- og eddiksyre, resp. Ci-C4-alkankarboksyl-syreklorider som acetylklorid. Omsetningen med disse foregår på vanlig måte hvis nødvendig i nærvær av en base, f.eks. av trietylamin eller pyridin, resp. i tilfelle av omsetningen med syreanhydrider i nærvær av mineralsyre, f.eks. av svovelsyre. Ci-C4-alkanoylating agents are, for example, Ci-C4-alkancarboxylic acid anhydrides such as acetic anhydride or the mixed anhydride of formic and acetic acid, resp. Ci-C4-alkanecarboxylic acid chlorides such as acetyl chloride. The turnover with these takes place in the usual way if necessary in the presence of a base, e.g. of triethylamine or pyridine, resp. in the case of the reaction with acid anhydrides in the presence of mineral acid, e.g. of sulfuric acid.
Oppdeling av isomerblandinger, som hvilke eksempelvis er å nevne blandinger av forbindelser med formel I, samt ifølge fremgangsmåten dannede isomerer av disse, foregår på vanlig måte. De kan eksempelvis adskilles på grunn av de forskjel-lige fysikalske egenskaper av komponentene ved vanlige fysikalske skillefremgangsmåter, f.eks. ved fraksjonert krystallisasjon, kromatografifremgangsmåter o.1. Separation of isomer mixtures, such as, for example, mixtures of compounds of formula I, as well as isomers thereof formed according to the method, takes place in the usual way. They can, for example, be separated due to the different physical properties of the components by normal physical separation methods, e.g. by fractional crystallisation, chromatography procedures etc.1.
Fremgangsmåter for fremstilling av nye utgangsstoffer, f.eks. med formel I', som spesielt ble utviklet for fremstilling av forbindelsene med formél I, spesielt ved utgangsstoffvalg som fører til de innledningsvis som foretrukket angitte forbindelser med formel I, samt deres anvendelse som mellomproduk-ter kan likeledes være en gjenstand for oppfinnelsen. Procedures for the production of new starting materials, e.g. with formula I', which was especially developed for the production of the compounds with formula I, especially by starting material selection that leads to the compounds with formula I indicated initially as preferred, as well as their use as intermediates can likewise be an object of the invention.
Oppfinnelsen skal forklares nærmere ved noen eksempler. The invention will be explained in more detail by some examples.
Eksempel 1 Example 1
73,5 g (0,25 mol) l-(o-fluorbenzyl)-lH-l,2,3-triazol-4 , 5-dikarboksylsyredimetylester oppløses i 1000 ml metanol. Deretter påpresser man i autoklav 250 g ammoniakk og hensetter i 24 timer ved 100°C. Deretter avkjøles, det utkrystalliserte produkt frasuges, vaskes med metanol, og omkrystalliseres fra dioksan/toluen. Man får l-(o-fluorben-zyl )-lH-l ,2 ,3-triazol-4 ,5-dikarboksamid av smp. 197-199-C. 73.5 g (0.25 mol) of 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxylic acid dimethyl ester are dissolved in 1000 ml of methanol. 250 g of ammonia are then pressed into the autoclave and left for 24 hours at 100°C. It is then cooled, the crystallized product is sucked off, washed with methanol, and recrystallized from dioxane/toluene. One obtains 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 197-199-C.
Utgangsmaterialet kan f.eks. fremstilles på følgende måte: Til en til 90°C oppvarmet oppløsning av 41,5 g (0,275 mol) o-fluor-benzylazid i 50 ml toluen dryppes en oppløsning av 40 g (0,282 mol) acetylendikarboksylsyredimetylester i 500 ml toluen. Etter 5 ytterligere timer ved 90" C fjerner man toluen og frasuger etter avkjøling de utkrystalliserte stoffer. Etter omkrystalllsering fra en blanding av dietyleter og petroleter (1:1) får man således l-(o-fluorben-zyl )-lH-l,2,3-triazol-4,5-dikarboksylsyredimetylester av smp. 49-51'C. The starting material can e.g. is prepared in the following way: To a solution of 41.5 g (0.275 mol) of o-fluorobenzylazide in 50 ml of toluene heated to 90°C, a solution of 40 g (0.282 mol) of acetylene dicarboxylic acid dimethyl ester in 500 ml of toluene is added dropwise. After 5 additional hours at 90°C, the toluene is removed and, after cooling, the crystallized substances are filtered off with suction. After recrystallization from a mixture of diethyl ether and petroleum ether (1:1), l-(o-fluorobenzyl)-lH-l, 2,3-triazole-4,5-dicarboxylic acid dimethyl ester of mp 49-51°C.
Eksempel 2 Example 2
59 g (0,26 mol) l-(o-fluorbenzyl)-lH-l,2, 3-triazol-4-karboksylsyrer oppvarmes med 300 ml tlonylklorld i 1 time ved tilbakeløp. Deretter destillerer man overskytende tlonylklorld 1 vakuum, oppløser det gjenværende l-(o-fluorbenzyl)-lH-1,2,3-trlazol-4-karboksylsyreklorid i 500 ml toluen og drypper denne oppløsning ved 5-10°C til 500 ml av en konsentrert vandig ammoniakkoppløsning. Det utfelte produkt frasuges, vaskes med vann og omkrystal11seres fra etanol. Man får således l-(o-fluorbenzyl)-lH-l,2,3-triazol-4-karboksamid av smp. 220-222°C. 59 g (0.26 mol) of 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acids are heated with 300 ml of thlonyl chloride for 1 hour at reflux. Excess tlonyl chloride is then distilled off under vacuum, the remaining 1-(o-fluorobenzyl)-1H-1,2,3-trilazole-4-carboxylic acid chloride is dissolved in 500 ml of toluene and this solution is added dropwise at 5-10°C to 500 ml of a concentrated aqueous ammonia solution. The precipitated product is filtered off with suction, washed with water and recrystallized from ethanol. One thus obtains 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of m.p. 220-222°C.
Utgangsmaterialet kan f.eks. fremstilles på følgende måte: The starting material can e.g. produced in the following way:
En oppløsning av 50 g (0,33 mol) o-fluorbenzylazid, 23,1 g (0,33 mol) propinkarboksylsyre og 400 ml toluen omrøres 24 timer ved 70°C. Det utfelte produkt frasuges etter avkjøling til værelsestemperatur og vaskes først med toluen og deretter med dietyleter. Man får således l-(o-fluorbenzyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 151°C under spaltning. A solution of 50 g (0.33 mol) o-fluorobenzylazide, 23.1 g (0.33 mol) propynecarboxylic acid and 400 ml toluene is stirred for 24 hours at 70°C. The precipitated product is filtered off after cooling to room temperature and washed first with toluene and then with diethyl ether. One thus obtains 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 151°C during decomposition.
Eksempel 3 Example 3
Analogt som omtalt i eksempel 1, vil man når det gås ut fra 2,6-difluorbenzylazid og acetylendikarboksylsyredimetyleter over l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksyl-syredimetylester (smp. 62-65°C) få l-(2,6-difluorbenzyl)-lH-1,2,3-trlazol-4,5-dikarboksamid av smp. 203-2O5<*>C (fra metanol). ;Eksempel 4 ;Analogt eksempel 2 vil man, når det gås ut fra 2,6-dif luor-benzylazid over l-(2 ,6-difluorbenzyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 160-162°C under spaltning (fra acetonitril) få l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid av smp. 273-24CC (fra etanol). ;Eksempel 5 ;Analogt som omtalt 1 eksempel 1-4 kan man videre fremstille: l-(2,3-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid, l-(2,4-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid og 1- (2,5-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid. ;Eksempel 6 ;På analog måte som omtalt i eksempel 2, vil man av l-(6-klor-2- fluor-benzyl)-lH-l,2,3-triazol-4-karboksylsyre få l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4-karboksamid av smp. 274-276°C (fra iseddik). ;Utgangsmaterialet kan f.eks. fremstilles på følgende måte: En blanding av 98 g (0,678 mol) 6-klor-2-fluor-toluen, 91,5 g (0,678 mol) sulfurylklorid, og 0,2 g dibenzoylperoksyd omrøres 3 timer ved 100-110°C og destilleres deretter. Man får således 6-klor-2-fluor-benzylklorid, kokepunkt15 = 78-82° C. ;Til en suspensjon av 47 g (0,722 mol) natriumazid i 400 ml dimetylsulfoksyd drypper man ved 20-40°C 123 g (0,687 mol) 6-klor-2-fluor-benzylklorid. Etter 4 timers omrøring ved værelsestemperatur fortynnes med 1 liter isvann og ekstrahe-res med cykloheksan. Etter oppløsningsmidlets avdestillering destillers resten. Man får således 6-klor-2-fluor-benzyl-azid, kokepunkt15 <=> 99-100°C. ;27,5 g (0,15 mol) 6-klor-2-fluor-benzylazid og 10,5 g (0,15 mol) propinkarboksylsyre i 300 ml toluen, oppvarmes 3 timer ved 90°C. Etter avkjøling frasuges krystallene, og omkrystalliseres fra acetonitril. Man får således l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 182°C under spaltning. ;Eksempel 7 ;På analog måte som omtalt i eksempel i vil man, når det gås ut fra 6-klor-2-fluor-benzylazid og acetylendikarboksylsyredimetylester over l-(6-klor-2-fluor-benzyl)-lH-l,2,3-trlazoi-4,5-dlkarboksylsyredlmetylester (smp. 88-90°C) få 1-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 214-216'C (fra iseddik). ;Eksempel 8 ;Analogt som omtalt i eksempel 1, vil man av 2,5-dif luorben-zylazid (kokepunkt15 = 82-84°C) over l-(2,5-difluor-benzyl)-1H-1,2,3-triazol-4,5-dikarboksylsyredimetylester få l-(2,5-difluorbenzyl )-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 191-192'C (fra dioksan/toluen). ;Eksempel 9 ;På analog måte som i eksempel 1, vil man av 2,4-dif luorben-zylazid (kokepunkt15 = 80-83°C) over 1-(2,4-difluorbenzyl)-1H-1,2,3-triazol-4,5-dikarboksylsyredimetylester av smp. 75-76°C (fra cykloheksan) få l-(2,4-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 183-185°C (fra dioksan/toluen ). ;Eksempel 10 ;Analogt eksempel 1, vil man ved omsetning med dimetylamid få 1 -(2,6-di f luorbenzyl)-lH-l, 2 , 3-triazol-4,5-dikarboksyl-syre(N,N-dimetyl)amid av smp. 130-133°C (fra tertiærbutoksymetan). ;Eksempel 11 ;Analogt eksempel 1, vil man av 2,3-difluorbenzylazid og acetylendikarboksylsyredimetylester over l-(2,3-difluorben-zyl )-lH-l,2,3-triazol-4,5-dlkarboksylsyredlmetylester få 1-(2,3-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 183-185°C (fra eddikester/benzen). ;Eksempel 12 ;Analogt eksempel 2 vil man av l-(2,6-difluorbenzyl)-5-metyl-1H-1,2,3-triazol-4-karboksylsyre få l-(2,6-difluorbenzyl )-5-metyl-lH-l,2,3-trIazol-4-karboksamid av smp. 208-210'C (fra metanol). ;Utgangsmaterialet fremstillés som følger: ;Man oppløser 2,53 g (0,11 mol) natrium i 60 ml alkohol, tilsetter deretter en blanding av 16,9 g (0,1 mol) 2,6-difluorbenzylazid og 14,3 g (0,11 mol) aceteddikester i 60 ml alkohol og oppvarmer 18 timer til tilbakeløp. Etter tilsetning av 120 ml n-natronlut lar man det koke ytterligere 2 timer under tilbakeløp, fortynner med 200 ml vann og surgjør under avkjøling med saltsyre til pH 1. Det utfelte produkt frasuges, vaskes først med vann, deretter med eter og tørkes. Man får således l-(2,6-difluorbenzyl)-5-metyl-lH-1,2,3-triazol-4-karboksylsyre av smp. 166-167°C. ;Eksempel 13 ;Analogt eksempel 1 vil man av l-[l-(2,6-difluorfenyl)-etyl]-1H-1,2,3-triazol-4-karboksylsyreetylester få l-[l-(2,6-difluorfenyl)etyl]-1H-1,2,3-triazol-4-karboksamid av smp. 205-207°C (fra metanol ). ;Utgangsmaterialet fremstilles som følger: ;Ved reduksjon av 10,2 g (66 mmol) 2,6-difluoracetofenon med 2,5 g (65 mmol) 1itiumaluminiumhydrid i eter får man l-(2,6-difluorfenyl )etanol som fargeløs olje. ;Man oppløser 10 g (63 mmol) l-(2,6-dlfluorfenyl)etanol i 150 ml nitrogenhydrogensyreoppløsning (1,2 N i toluen), tilsetter 22,8 g (200 mmol) tr if luoreddiksyre, og lar det henstå I 24 timer ved værelsestemperatur. Etter fortynning med 300 ml heksan, vasker man først med vann, deretter med natriumbikar-bonatoppløsning syrefritt, tørker over natrlumsulfat og fjerner oppløsningsmidlet ved 40-50°C under nedsatt trykk. Resten oppløser man 1 100 ml heksan, filtrerer gjennom 50 g kiselgel og inndamper igjen. Man får således l-(2,6-difluorfenyl)-etylazid som fargeløs olje. ;6,5 g (35 mmol) l-( 2,6-dif luorfenyl )etylazid og 2,45 g (35 mmol) propinkarboksylsyre i 50 ml toluen oppvarmer man 24 timer ved 60-70°C. Etter avkjøling ekstraherer man med 100 ml n-natronlut, og får etter surgjøring med saltsyre 1-[1-(2,6-difluorfenyletyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 135-138°C under spaltning. ;7,1 g (26,6 mmol) l-[l-(2,6-difluorfenyl)etyl]-1H-1,2,3-triazol-4-karboksylsyre oppvarmes med 150 ml etanol og 1 ml svovelsyre i 10 timer under tilbakeløp. Etter opparbeidelse får man l-[l-(2,6-difluorfenyl)etyl]-1H-1,2,3-triazol-4-karboksylsyre-etylester av smp. 118-121°C. ;Eksempel 14 ;Analogt eksempel 1 vil man av l-{2-[2-(2,6-difluorfenyl)-propyl]>-lH-l,2,3-triazol-4-karboksylsyre få l-{2-[2-(2,6-difluorfenyl)propyl]}-lH-l,2,3-triazol-4-karboksamid av smp. 203-205°C (fra metanol). ;Utgangsmaterialet fremstilles som følger: ;Til 28 g (150 mmol) 2,6-dif luorbenzosyreetylester i 200 ml eter drypper man langsomt 120 ml av en 3-molar oppløsning av metylmagnesiumklorid i tetrahydrofuran. Etter 1 times tilbakeløp opparbeides med 105^-ig ammoniumkloridoppløsning får man 2-(2,6-difluorfenyl)-propan-2-ol (kokepunkt-^ = 74-76°C). 20,6 g (120 mmol) 2-(2,6-difluorfenyl)-propan-2-ol oppløses i 300 ml nitrogenhydrogensyreoppløsning (IN i benzen) og blandes med med 22,8 g (200 mmol) trifluoreddiksyre. Etter 24 timer ved værelsestemperatur fortynnes med heksan, vaskes med vann og deretter med natriumbikarbonatoppløsning syrefritt, tørkes med natriumsulfat, oppløsningsmidlet fordampes og resten destilleres. Man får således 2-(2,6-difluorfenyl )-2-azido-propan (kokepunkt-^ = 85-87°C). 10 g (51 mmol) 2-(2,6-difluorfenyl)-2-azido-propan omsettes med 3,6 g (51 mmol) propinkarboksylsyre i 100 ml toluen og opparbeides som omtalt i eksempel 13. Man får således l-{2-[2-( 2 , 6-dif luorfenyl )propyl]}-lH-l,2,3-triazol-4-karboksyl-syre av smp. 173° C under spaltning. ;Etter forestring av denne syre med 50 ml etanol og 0,5 ml kons. svovelsyre, får man l-{2-[2-(2,6-difluorfenyl)propyl])-1H-1,2,3-triazol-4-karboksylsyre som lysegul, tyktflytende olje, som kan anvendes uten ytterligere rensing for omsetningen med ammoniakk. ;Eksempel 15 ;Analogt eksempel 1 vil man, får det gås ut fra 2-(2,6-difluorfenyl)-2-azido-propan og acetylendikarboksylsyredimetylester over l-{2-[2-(2,6-difluorfenyl)propyl]}-lH-l,2,3-triazol-4,5-dikarboksylsyredimetylester (smp. 100-102°C) få l-{2-[2-(2,6-difluorfenyl)-propyl]>-lH-l ,2 , 3-1r iazol-4,5-dikarboksamid av smp. 177-178°C (fra eddikester/heksan). ;Eksempel 16 ;16,9 g (0,1 mol) 2,6-difluorbenzylazid og 8,3 g (0,1 mol) but-2-in-karboksamid oppvarmes i 20 ml dioksan i 16 timer ved 100°C. Etter dioksanets avdampning, adskilles den ønskede isomere ved søylekromatografi. Man får således l-(2,6-difluorbenzyl)-5-metyl-lH-l,2,3-triazol-4-karboksamid av smp. 208-210°C, (fra metanol ). ;Eksempel 17 ;2,81 g (10 mmol) l-(2,6-difluorfenyl)-lH-l,2,3-triazol-4,5-dikarboksamid, 20 ml acetanhydrid og 2 dråper svovelsyre, oppvarmes i 3 timer ved 80°C. Etter avkjøling utrører man med 100 ml vann i 1 time ved 20-25°C, frasuger det utfelte produkt og vasker med vann. Etter omkrystallisering fra 75 ml metanol får man således l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4,5-di(N-acetyl)karboksamid av smp. 136-i38°C. ;Eksempel 18 ;På analog måte som i eksempel 17, får man også l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4-(N-acetyl)-karboksamid av smp. 205-207°C (fra dioksan-toluen). ;Eksempel 19 ;1,4 g (12,5 mmol) acetylendikarboksylsyrediamid oppløses ved 60<*>C i 10 ml dimetylsulfoksyd. Man tilsetter 1,69 g (10 mmol) 2,6-difluorbenzylazid og lar det omrøre i 16 timer ved 80°C. Analogous to that discussed in example 1, when starting from 2,6-difluorobenzyl azide and acetylenedicarboxylic acid dimethyl ether over 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxylic acid dimethyl ester ( m.p. 62-65°C) give 1-(2,6-difluorobenzyl)-1H-1,2,3-trilazole-4,5-dicarboxamide of m.p. 203-2O5<*>C (from methanol). ;Example 4 ;Analogous to example 2, when starting from 2,6-difluorobenzylazide over 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 160-162°C with decomposition (from acetonitrile) obtain 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of m.p. 273-24CC (from ethanol). ;Example 5 ;Analogously as described in examples 1-4, one can further prepare: 1-(2,3-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide, 1-(2,4-difluorobenzyl) -1H-1,2,3-triazole-4-carboxamide and 1-(2,5-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide. ;Example 6 ;In an analogous way as described in example 2, from l-(6-chloro-2-fluoro-benzyl)-lH-1,2,3-triazole-4-carboxylic acid, l-(6-chloro -2-fluoro-benzyl)-1H-1,2,3-triazole-4-carboxamide of m.p. 274-276°C (from glacial acetic acid). ;The starting material can e.g. is prepared as follows: A mixture of 98 g (0.678 mol) 6-chloro-2-fluorotoluene, 91.5 g (0.678 mol) sulfuryl chloride, and 0.2 g dibenzoyl peroxide is stirred for 3 hours at 100-110°C and is then distilled. 6-Chloro-2-fluoro-benzyl chloride is thus obtained, boiling point 15 = 78-82° C. To a suspension of 47 g (0.722 mol) of sodium azide in 400 ml of dimethylsulfoxide, 123 g (0.687 mol ) 6-chloro-2-fluoro-benzyl chloride. After stirring for 4 hours at room temperature, dilute with 1 liter of ice water and extract with cyclohexane. After the solvent has been distilled off, the residue is distilled. Thus, 6-chloro-2-fluoro-benzyl-azide is obtained, boiling point 15 <=> 99-100°C. 27.5 g (0.15 mol) of 6-chloro-2-fluoro-benzylazide and 10.5 g (0.15 mol) of propynecarboxylic acid in 300 ml of toluene are heated for 3 hours at 90°C. After cooling, the crystals are suctioned off and recrystallized from acetonitrile. One thus obtains 1-(6-chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 182°C during decomposition. ;Example 7 ;In an analogous way as discussed in example i, when starting from 6-chloro-2-fluoro-benzylazide and acetylenedicarboxylic acid dimethyl ester over l-(6-chloro-2-fluoro-benzyl)-lH-l, 2,3-trilazo-4,5-dlcarboxylic acid dlmethyl ester (m.p. 88-90°C) get 1-(6-chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 214-216'C (from glacial acetic acid). ;Example 8 ;Analogously as described in example 1, one wants from 2,5-difluorobenzylazide (boiling point 15 = 82-84°C) over 1-(2,5-difluoro-benzyl)-1H-1,2, 3-triazole-4,5-dicarboxylic acid dimethyl ester obtain 1-(2,5-difluorobenzyl )-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 191-192°C (from dioxane/toluene). ;Example 9 ;In an analogous way as in example 1, 2,4-difluorobenzylazide (boiling point 15 = 80-83°C) over 1-(2,4-difluorobenzyl)-1H-1,2,3 -triazole-4,5-dicarboxylic acid dimethyl ester of m.p. 75-76°C (from cyclohexane) obtain 1-(2,4-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 183-185°C (from dioxane/toluene). ;Example 10 ;Analogous to example 1, by reaction with dimethylamide, 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxylic acid (N,N-dimethyl )amide of m.p. 130-133°C (from tertiary butoxymethane). ;Example 11 ;Analogous to example 1, one will get 1-( 2,3-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 183-185°C (from acetic ester/benzene). ;Example 12 ;Analogous to example 2, from l-(2,6-difluorobenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid, l-(2,6-difluorobenzyl)-5- methyl-1H-1,2,3-triazole-4-carboxamide of m.p. 208-210°C (from methanol). ;The starting material is prepared as follows: ;One dissolves 2.53 g (0.11 mol) of sodium in 60 ml of alcohol, then adds a mixture of 16.9 g (0.1 mol) of 2,6-difluorobenzylazide and 14.3 g (0.11 mol) of acetic acid ester in 60 ml of alcohol and heat to reflux for 18 hours. After adding 120 ml of sodium hydroxide solution, it is allowed to boil for a further 2 hours under reflux, diluted with 200 ml of water and acidified while cooling with hydrochloric acid to pH 1. The precipitated product is filtered off with suction, washed first with water, then with ether and dried. One thus obtains 1-(2,6-difluorobenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid of m.p. 166-167°C. ;Example 13 ;Analogous to example 1, from l-[l-(2,6-difluorophenyl)-ethyl]-1H-1,2,3-triazole-4-carboxylic acid ethyl ester, l-[l-(2,6- difluorophenyl)ethyl]-1H-1,2,3-triazole-4-carboxamide of m.p. 205-207°C (from methanol). ;The starting material is prepared as follows: ;By reducing 10.2 g (66 mmol) of 2,6-difluoroacetophenone with 2.5 g (65 mmol) of lithium aluminum hydride in ether, 1-(2,6-difluorophenyl)ethanol is obtained as a colorless oil . ;One dissolves 10 g (63 mmol) of 1-(2,6-difluorophenyl)ethanol in 150 ml of nitric acid solution (1.2 N in toluene), adds 22.8 g (200 mmol) of trifluoroacetic acid, and allows it to stand 24 hours at room temperature. After dilution with 300 ml of hexane, it is first washed with water, then with acid-free sodium bicarbonate solution, dried over sodium sulfate and the solvent is removed at 40-50°C under reduced pressure. The residue is dissolved in 1,100 ml of hexane, filtered through 50 g of silica gel and evaporated again. Thus, 1-(2,6-difluorophenyl)-ethyl azide is obtained as a colorless oil. 6.5 g (35 mmol) of 1-(2,6-difluorophenyl)ethylazide and 2.45 g (35 mmol) of propynecarboxylic acid in 50 ml of toluene are heated for 24 hours at 60-70°C. After cooling, it is extracted with 100 ml of n-sodium hydroxide solution, and after acidification with hydrochloric acid, 1-[1-(2,6-difluorophenylethyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 135-138°C during decomposition. ; 7.1 g (26.6 mmol) of 1-[1-(2,6-difluorophenyl)ethyl]-1H-1,2,3-triazole-4-carboxylic acid is heated with 150 ml of ethanol and 1 ml of sulfuric acid for 10 hours during reflux. After working up, 1-[1-(2,6-difluorophenyl)ethyl]-1H-1,2,3-triazole-4-carboxylic acid ethyl ester of m.p. 118-121°C. ;Example 14 ;Analogous to example 1, from l-{2-[2-(2,6-difluorophenyl)-propyl]>-lH-1,2,3-triazole-4-carboxylic acid, l-{2-[ 2-(2,6-difluorophenyl)propyl]}-1H-1,2,3-triazole-4-carboxamide of m.p. 203-205°C (from methanol). ;The starting material is prepared as follows: ;To 28 g (150 mmol) of 2,6-difluorobenzoic acid ethyl ester in 200 ml of ether, slowly add 120 ml of a 3-molar solution of methylmagnesium chloride in tetrahydrofuran. After refluxing for 1 hour, working up with 105^-ig ammonium chloride solution yields 2-(2,6-difluorophenyl)-propan-2-ol (boiling point-^ = 74-76°C). 20.6 g (120 mmol) of 2-(2,6-difluorophenyl)-propan-2-ol are dissolved in 300 ml of nitric acid solution (IN in benzene) and mixed with 22.8 g (200 mmol) of trifluoroacetic acid. After 24 hours at room temperature, dilute with hexane, wash with water and then with acid-free sodium bicarbonate solution, dry with sodium sulfate, evaporate the solvent and distill the residue. This gives 2-(2,6-difluorophenyl)-2-azidopropane (boiling point = 85-87°C). 10 g (51 mmol) of 2-(2,6-difluorophenyl)-2-azido-propane are reacted with 3.6 g (51 mmol) of propynecarboxylic acid in 100 ml of toluene and worked up as described in example 13. One thus obtains l-{ 2-[2-(2,6-difluorophenyl)propyl]}-1H-1,2,3-triazole-4-carboxylic acid of m.p. 173° C during decomposition. ;After esterification of this acid with 50 ml ethanol and 0.5 ml conc. sulfuric acid, 1-{2-[2-(2,6-difluorophenyl)propyl])-1H-1,2,3-triazole-4-carboxylic acid is obtained as a pale yellow, viscous oil, which can be used without further purification for the reaction with ammonia. ;Example 15 ;Analogous example 1 is desired, starting from 2-(2,6-difluorophenyl)-2-azido-propane and acetylenedicarboxylic acid dimethyl ester over l-{2-[2-(2,6-difluorophenyl)propyl] }-lH-l,2,3-triazole-4,5-dicarboxylic acid dimethyl ester (m.p. 100-102°C) get l-{2-[2-(2,6-difluorophenyl)-propyl]>-lH-l ,2 , 3-1r iazole-4,5-dicarboxamide of m.p. 177-178°C (from acetic acid/hexane). ;Example 16 ;16.9 g (0.1 mol) of 2,6-difluorobenzylazide and 8.3 g (0.1 mol) of but-2-yne carboxamide are heated in 20 ml of dioxane for 16 hours at 100°C. After the evaporation of the dioxane, the desired isomers are separated by column chromatography. One thus obtains 1-(2,6-difluorobenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide of m.p. 208-210°C, (from methanol). ;Example 17 ;2.81 g (10 mmol) 1-(2,6-difluorophenyl)-1H-1,2,3-triazole-4,5-dicarboxamide, 20 ml of acetic anhydride and 2 drops of sulfuric acid, heated for 3 hours at 80°C. After cooling, stir with 100 ml of water for 1 hour at 20-25°C, filter off the precipitated product and wash with water. After recrystallization from 75 ml of methanol, 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-di(N-acetyl)carboxamide of m.p. 136-i38°C. ;Example 18 ;In an analogous way as in example 17, one also obtains 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-(N-acetyl)-carboxamide of m.p. 205-207°C (from dioxane-toluene). Example 19 1.4 g (12.5 mmol) of acetylene dicarboxylic acid diamide is dissolved at 60<*>C in 10 ml of dimethylsulfoxide. 1.69 g (10 mmol) of 2,6-difluorobenzylazide is added and it is allowed to stir for 16 hours at 80°C.
Man fortynner med 25 mi vann, frasuger, utrører med 50 ml vann og lar det omrøre 30 minutter ved 50-60° C, frasuger igjen, tørker og omkrystalliserer fra dioksan/etanol. Man får l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 203-205°C. It is diluted with 25 ml of water, aspirated, stirred with 50 ml of water and allowed to stir for 30 minutes at 50-60° C, aspirated again, dried and recrystallized from dioxane/ethanol. One obtains 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 203-205°C.
Claims (5)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH166385 | 1985-04-18 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO861486L NO861486L (en) | 1986-10-20 |
NO164295B true NO164295B (en) | 1990-06-11 |
NO164295C NO164295C (en) | 1990-09-19 |
Family
ID=4215715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO861486A NO164295C (en) | 1985-04-18 | 1986-04-16 | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS. |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0199262B1 (en) |
JP (1) | JPS61243068A (en) |
KR (1) | KR900008810B1 (en) |
AU (1) | AU599024B2 (en) |
CA (1) | CA1272201A (en) |
CY (1) | CY1751A (en) |
DD (1) | DD245874A5 (en) |
DE (1) | DE3677626D1 (en) |
DK (1) | DK169720B1 (en) |
ES (2) | ES8800176A1 (en) |
FI (1) | FI93544C (en) |
GR (1) | GR861004B (en) |
HK (1) | HK1494A (en) |
HU (1) | HU203327B (en) |
IE (1) | IE58472B1 (en) |
IL (1) | IL78510A (en) |
MX (1) | MX9203628A (en) |
NO (1) | NO164295C (en) |
NZ (1) | NZ215871A (en) |
PH (1) | PH22568A (en) |
PT (1) | PT82400B (en) |
ZA (1) | ZA862873B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0151528B1 (en) * | 1984-02-02 | 1990-07-04 | Merck & Co. Inc. | 5-(amino or substituted amino)-1,2,3-triazoles |
AU2633897A (en) * | 1996-04-19 | 1997-11-12 | Novo Nordisk A/S | Solid phase and combinatorial synthesis of substituted 1,2,3-triazoles and of arrays of substituted 1,2,3-triazoles |
KR100481137B1 (en) * | 1996-07-11 | 2005-04-08 | 노파르티스 아게 | Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
TW403740B (en) | 1997-06-10 | 2000-09-01 | Novartis Ag | Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide |
TW513301B (en) * | 1999-03-01 | 2002-12-11 | Novartis Ag | Pharmaceutical composition for treatment of neuropathic pain and affective and attention disorders |
WO2004106329A2 (en) * | 2003-06-03 | 2004-12-09 | Dr. Reddy's Laboratories Ltd. | Novel antiinfective compounds and their pharmaceutical compositions |
IT1393368B1 (en) * | 2009-03-23 | 2012-04-20 | Dipharma Francis Srl | METHOD FOR THE PREPARATION OF RUFINAMIDE |
IT1395736B1 (en) | 2009-08-04 | 2012-10-19 | Dipharma Francis Srl | CRYSTALLINE FORMS OF RUFINAMIDE |
US8884026B2 (en) * | 2010-04-30 | 2014-11-11 | Laboratorios Lesvi, S.L. | Process for preparing rufinamide intermediate |
ITMI20110718A1 (en) | 2011-04-29 | 2012-10-30 | Dipharma Francis Srl | PROCEDURE FOR PURIFICATION OF RUFINAMIDE |
US20150368211A1 (en) * | 2013-01-31 | 2015-12-24 | The Johns Hopkins University | Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels |
US9771335B2 (en) * | 2015-07-31 | 2017-09-26 | The Johns Hopkins University | Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels |
ES2902685T3 (en) | 2015-12-11 | 2022-03-29 | Univ Aarhus | Rufinamide for use in the treatment of myotonia |
WO2021099481A1 (en) | 2019-11-20 | 2021-05-27 | Medichem, S.A. | Solid composition containing rufinamide |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1511195A (en) * | 1976-10-18 | 1978-05-17 | Ici America Inc | Triazole derivatives |
FI834666A (en) * | 1982-12-23 | 1984-06-24 | Ciba Geigy Ag | FOERFARANDE FOER FRAMSTAELLNING AV NYA ARALKYLTRIAZOLFOERENINGAR. |
-
1986
- 1986-04-14 FI FI861573A patent/FI93544C/en not_active IP Right Cessation
- 1986-04-14 PH PH33651A patent/PH22568A/en unknown
- 1986-04-15 EP EP86105188A patent/EP0199262B1/en not_active Expired - Lifetime
- 1986-04-15 DE DE8686105188T patent/DE3677626D1/en not_active Expired - Lifetime
- 1986-04-15 IL IL78510A patent/IL78510A/en not_active IP Right Cessation
- 1986-04-16 ES ES554024A patent/ES8800176A1/en not_active Expired
- 1986-04-16 CA CA000506774A patent/CA1272201A/en not_active Expired - Lifetime
- 1986-04-16 GR GR861004A patent/GR861004B/en unknown
- 1986-04-16 DD DD86289243A patent/DD245874A5/en not_active IP Right Cessation
- 1986-04-16 NO NO861486A patent/NO164295C/en unknown
- 1986-04-16 PT PT82400A patent/PT82400B/en unknown
- 1986-04-17 AU AU56319/86A patent/AU599024B2/en not_active Expired
- 1986-04-17 HU HU861615A patent/HU203327B/en unknown
- 1986-04-17 KR KR1019860002954A patent/KR900008810B1/en not_active IP Right Cessation
- 1986-04-17 ZA ZA862873A patent/ZA862873B/en unknown
- 1986-04-17 IE IE101586A patent/IE58472B1/en not_active IP Right Cessation
- 1986-04-17 DK DK175686A patent/DK169720B1/en not_active IP Right Cessation
- 1986-04-17 NZ NZ215871A patent/NZ215871A/en unknown
- 1986-04-18 JP JP61088384A patent/JPS61243068A/en active Granted
-
1987
- 1987-07-31 ES ES557641A patent/ES8802501A1/en not_active Expired
-
1992
- 1992-06-26 MX MX9203628A patent/MX9203628A/en unknown
-
1994
- 1994-01-06 HK HK14/94A patent/HK1494A/en not_active IP Right Cessation
- 1994-06-03 CY CY175194A patent/CY1751A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO164295B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS. | |
US9096570B2 (en) | Process for manufacturing substituted 3-pyridylmethyl ammonium bromides | |
US20110245506A1 (en) | Process for Manufacturing Substituted 5-Methoxymethylpyridine-2,3-Dicarboxylic Acid Derivatives | |
JPH0468310B2 (en) | ||
US4242261A (en) | Production of methylene-cycloamines | |
EP1272480B1 (en) | Method for the production of spirocyclic tetronic acid derivatives | |
US4692524A (en) | Process for the preparation of pyrimidine derivatives | |
US4143227A (en) | Process for substituted 5-benzyl-2,4-diamino-pyrimidines | |
NO834770L (en) | PROCEDURE FOR THE PREPARATION OF NEW ARALKYLTRIAZOL COMPOUNDS | |
US5011927A (en) | Preparation of 2-amino-4-fluoropyrimidine derivatives | |
US4990620A (en) | Halogen substituted pyridylalkyl ketones | |
EP0708095A1 (en) | Process for the preparation of alkoxytriazoles | |
US5663365A (en) | Process for the preparation of pyrazolones | |
JPH0468309B2 (en) | ||
SU523638A3 (en) | Method for preparing imidazole derivatives or their salts | |
NO312027B1 (en) | Process for the preparation of O- (3-amino-2-hydroxypropyl) hydroxymic acid halides | |
US20040199002A1 (en) | Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor | |
FI77233C (en) | FOERFARANDE FOER FRAMSTAELLNING AV 6-AMINONIKOTINSYRAS NIKOTINYLESTER. | |
US5623076A (en) | Process for the preparation of chloromethylpyridines | |
JP2804559B2 (en) | Method for producing 2-chloro-5-chloromethylpyridine | |
US4408044A (en) | Preparation of 3,6-disubstituted 4-amino-1,2,4-triazin-5-ones | |
US5541332A (en) | Chloropyridinium chlorides and process for their preparation | |
JPH06166666A (en) | Hydrazone derivative and its production | |
US4115398A (en) | Isoindoline derivatives and the acid addition salts thereof and process for the preparation of same | |
EP0298543B1 (en) | Thiapentanamide derivatives |